Friday, April 1, 2022

Scientific consortium provides real-time risk assessment of SARS-CoV-2 variants on immune protection

A new program has been set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

from Top Health News -- ScienceDaily https://ift.tt/O4agSyV

No comments:

Post a Comment

People who lost the most weight on Ozempic saw huge health benefits

People who lost significant weight while taking Ozempic, Wegovy, Mounjaro, or Saxenda had sharply lower risks of major obesity-related healt...